0.017094 0.000000 0.000000 0.000000 0.011338 0.000000 0.000000 0.000000 0.010616 0.00000 0.00000 0.00000 Hong, L. Zhang, X.-J. Foundling, S. Hartsuck, J.A. Tang, J. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 16 90.00 90.00 90.00 58.500 88.200 94.200 C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking H2 O 18.015 WATER non-polymer C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H11 N O2 S 149.211 y METHIONINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C11 H12 N2 O2 204.225 y TRYPTOPHAN L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C28 H52 N8 O6 596.762 N-[[1-[N-ACETAMIDYL]-[1-CYCLOHEXYLMETHYL-2-HYDROXY-4-ISOPROPYL]-BUT-4-YL]-CARBONYL]-GLUTAMINYL-ARGINYL-AMIDE non-polymer C5 H11 N O2 117.146 y VALINE L-peptide linking NE FEBS Lett. FEBLAL 0165 0014-5793 420 11 16 10.1016/S0014-5793(97)01477-4 9450540 Structure of a G48H mutant of HIV-1 protease explains how glycine-48 replacements produce mutants resistant to inhibitor drugs. 1997 10.2210/pdb1a9m/pdb pdb_00001a9m 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 293 1 AREA DETECTOR 1996-04 SIEMENS NI FILTER M x-ray 1 1.5418 1.0 1.5418 10884.852 HIV-1 PROTEASE G48H 2 man polymer 596.762 N-[[1-[N-ACETAMIDYL]-[1-CYCLOHEXYLMETHYL-2-HYDROXY-4-ISOPROPYL]-BUT-4-YL]-CARBONYL]-GLUTAMINYL-ARGINYL-AMIDE 1 syn non-polymer 18.015 water 59 nat water no no PQITLWQRPLVTIKIGGQLKEALLDTGADDTVLEEMSLPGRWKPKMIHGIGGFIKVRQYDQILIEICGHKAIGTVLVGPT PVNIIGRNLLTQIGCTLNF PQITLWQRPLVTIKIGGQLKEALLDTGADDTVLEEMSLPGRWKPKMIHGIGGFIKVRQYDQILIEICGHKAIGTVLVGPT PVNIIGRNLLTQIGCTLNF A,B polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n Lentivirus Escherichia Escherichia coli sample 11676 Human immunodeficiency virus 1 511693 Escherichia coli BL21 BL21 PET3B 1 2.8 55.90 VAPOR DIFFUSION 6.8 THE PROTEIN SOLUTION CONTAINED 6.5 MG/ML MUTANT HIV-1 PROTEASE IN 20 MM SODIUM ACETATE, 1 MM DITHIOTHREITOL, PH 5.5, WITH A 10-FOLD MOLAR EXCESS OF INHIBITOR. THE RESERVOIR SOLUTIONS FOR THE VAPOR DIFFUSION CONTAINED 10% DIMETHYLSULFOXIDE, 30 MM B-MERCAPTOETHANOL AND 4% 2-PROPANOL IN ADDITION TO THE PRECIPITANT. THE MOST FAVORABLE CRYSTALLIZATION CONDITIONS WERE 42% SATURATED AMMONIUM SULFATE, PH 6.8., vapor diffusion 5.5-6.8 database_2 pdbx_database_status struct_ref_seq_dif struct_site pdbx_initial_refinement_model repository Initial release Version format compliance Version format compliance Database references Derived calculations Other Refinement description 1 0 1998-06-17 1 1 2008-03-03 1 2 2011-07-13 1 3 2021-11-03 1 4 2023-08-02 _database_2.pdbx_DOI _database_2.pdbx_database_accession _pdbx_database_status.process_site _struct_ref_seq_dif.details _struct_site.pdbx_auth_asym_id _struct_site.pdbx_auth_comp_id _struct_site.pdbx_auth_seq_id Y BNL 1998-04-08 REL U0E N-[[1-[N-ACETAMIDYL]-[1-CYCLOHEXYLMETHYL-2-HYDROXY-4-ISOPROPYL]-BUT-4-YL]-CARBONYL]-GLUTAMINYL-ARGINYL-AMIDE HOH water 1GNO PDB ENTRY 1GNO PDB experimental model U0E 1 2 U0E U0E 100 B HOH 3 3 HOH HOH 100 A HOH 4 3 HOH HOH 101 A HOH 7 3 HOH HOH 102 A HOH 8 3 HOH HOH 103 A HOH 9 3 HOH HOH 104 A HOH 11 3 HOH HOH 105 A HOH 12 3 HOH HOH 106 A HOH 13 3 HOH HOH 107 A HOH 14 3 HOH HOH 108 A HOH 19 3 HOH HOH 109 A HOH 22 3 HOH HOH 110 A HOH 23 3 HOH HOH 111 A HOH 25 3 HOH HOH 112 A HOH 31 3 HOH HOH 113 A HOH 33 3 HOH HOH 114 A HOH 34 3 HOH HOH 115 A HOH 38 3 HOH HOH 116 A HOH 43 3 HOH HOH 117 A HOH 44 3 HOH HOH 118 A HOH 52 3 HOH HOH 119 A HOH 53 3 HOH HOH 120 A HOH 55 3 HOH HOH 121 A HOH 56 3 HOH HOH 122 A HOH 57 3 HOH HOH 123 A HOH 58 3 HOH HOH 124 A HOH 59 3 HOH HOH 125 A HOH 1 3 HOH HOH 101 B HOH 2 3 HOH HOH 102 B HOH 5 3 HOH HOH 103 B HOH 6 3 HOH HOH 104 B HOH 10 3 HOH HOH 105 B HOH 15 3 HOH HOH 106 B HOH 16 3 HOH HOH 107 B HOH 17 3 HOH HOH 108 B HOH 18 3 HOH HOH 109 B HOH 20 3 HOH HOH 110 B HOH 21 3 HOH HOH 111 B HOH 24 3 HOH HOH 112 B HOH 26 3 HOH HOH 113 B HOH 27 3 HOH HOH 114 B HOH 28 3 HOH HOH 115 B HOH 29 3 HOH HOH 116 B HOH 30 3 HOH HOH 117 B HOH 32 3 HOH HOH 118 B HOH 35 3 HOH HOH 119 B HOH 36 3 HOH HOH 120 B HOH 37 3 HOH HOH 121 B HOH 39 3 HOH HOH 122 B HOH 40 3 HOH HOH 123 B HOH 41 3 HOH HOH 124 B HOH 42 3 HOH HOH 125 B HOH 45 3 HOH HOH 126 B HOH 46 3 HOH HOH 127 B HOH 47 3 HOH HOH 128 B HOH 48 3 HOH HOH 129 B HOH 49 3 HOH HOH 130 B HOH 50 3 HOH HOH 131 B HOH 51 3 HOH HOH 132 B HOH 54 3 HOH HOH 133 B PRO 1 n 1 PRO 1 A GLN 2 n 2 GLN 2 A ILE 3 n 3 ILE 3 A THR 4 n 4 THR 4 A LEU 5 n 5 LEU 5 A TRP 6 n 6 TRP 6 A GLN 7 n 7 GLN 7 A ARG 8 n 8 ARG 8 A PRO 9 n 9 PRO 9 A LEU 10 n 10 LEU 10 A VAL 11 n 11 VAL 11 A THR 12 n 12 THR 12 A ILE 13 n 13 ILE 13 A LYS 14 n 14 LYS 14 A ILE 15 n 15 ILE 15 A GLY 16 n 16 GLY 16 A GLY 17 n 17 GLY 17 A GLN 18 n 18 GLN 18 A LEU 19 n 19 LEU 19 A LYS 20 n 20 LYS 20 A GLU 21 n 21 GLU 21 A ALA 22 n 22 ALA 22 A LEU 23 n 23 LEU 23 A LEU 24 n 24 LEU 24 A ASP 25 n 25 ASP 25 A THR 26 n 26 THR 26 A GLY 27 n 27 GLY 27 A ALA 28 n 28 ALA 28 A ASP 29 n 29 ASP 29 A ASP 30 n 30 ASP 30 A THR 31 n 31 THR 31 A VAL 32 n 32 VAL 32 A LEU 33 n 33 LEU 33 A GLU 34 n 34 GLU 34 A GLU 35 n 35 GLU 35 A MET 36 n 36 MET 36 A SER 37 n 37 SER 37 A LEU 38 n 38 LEU 38 A PRO 39 n 39 PRO 39 A GLY 40 n 40 GLY 40 A ARG 41 n 41 ARG 41 A TRP 42 n 42 TRP 42 A LYS 43 n 43 LYS 43 A PRO 44 n 44 PRO 44 A LYS 45 n 45 LYS 45 A MET 46 n 46 MET 46 A ILE 47 n 47 ILE 47 A HIS 48 n 48 HIS 48 A GLY 49 n 49 GLY 49 A ILE 50 n 50 ILE 50 A GLY 51 n 51 GLY 51 A GLY 52 n 52 GLY 52 A PHE 53 n 53 PHE 53 A ILE 54 n 54 ILE 54 A LYS 55 n 55 LYS 55 A VAL 56 n 56 VAL 56 A ARG 57 n 57 ARG 57 A GLN 58 n 58 GLN 58 A TYR 59 n 59 TYR 59 A ASP 60 n 60 ASP 60 A GLN 61 n 61 GLN 61 A ILE 62 n 62 ILE 62 A LEU 63 n 63 LEU 63 A ILE 64 n 64 ILE 64 A GLU 65 n 65 GLU 65 A ILE 66 n 66 ILE 66 A CYS 67 n 67 CYS 67 A GLY 68 n 68 GLY 68 A HIS 69 n 69 HIS 69 A LYS 70 n 70 LYS 70 A ALA 71 n 71 ALA 71 A ILE 72 n 72 ILE 72 A GLY 73 n 73 GLY 73 A THR 74 n 74 THR 74 A VAL 75 n 75 VAL 75 A LEU 76 n 76 LEU 76 A VAL 77 n 77 VAL 77 A GLY 78 n 78 GLY 78 A PRO 79 n 79 PRO 79 A THR 80 n 80 THR 80 A PRO 81 n 81 PRO 81 A VAL 82 n 82 VAL 82 A ASN 83 n 83 ASN 83 A ILE 84 n 84 ILE 84 A ILE 85 n 85 ILE 85 A GLY 86 n 86 GLY 86 A ARG 87 n 87 ARG 87 A ASN 88 n 88 ASN 88 A LEU 89 n 89 LEU 89 A LEU 90 n 90 LEU 90 A THR 91 n 91 THR 91 A GLN 92 n 92 GLN 92 A ILE 93 n 93 ILE 93 A GLY 94 n 94 GLY 94 A CYS 95 n 95 CYS 95 A THR 96 n 96 THR 96 A LEU 97 n 97 LEU 97 A ASN 98 n 98 ASN 98 A PHE 99 n 99 PHE 99 A PRO 1 n 1 PRO 1 B GLN 2 n 2 GLN 2 B ILE 3 n 3 ILE 3 B THR 4 n 4 THR 4 B LEU 5 n 5 LEU 5 B TRP 6 n 6 TRP 6 B GLN 7 n 7 GLN 7 B ARG 8 n 8 ARG 8 B PRO 9 n 9 PRO 9 B LEU 10 n 10 LEU 10 B VAL 11 n 11 VAL 11 B THR 12 n 12 THR 12 B ILE 13 n 13 ILE 13 B LYS 14 n 14 LYS 14 B ILE 15 n 15 ILE 15 B GLY 16 n 16 GLY 16 B GLY 17 n 17 GLY 17 B GLN 18 n 18 GLN 18 B LEU 19 n 19 LEU 19 B LYS 20 n 20 LYS 20 B GLU 21 n 21 GLU 21 B ALA 22 n 22 ALA 22 B LEU 23 n 23 LEU 23 B LEU 24 n 24 LEU 24 B ASP 25 n 25 ASP 25 B THR 26 n 26 THR 26 B GLY 27 n 27 GLY 27 B ALA 28 n 28 ALA 28 B ASP 29 n 29 ASP 29 B ASP 30 n 30 ASP 30 B THR 31 n 31 THR 31 B VAL 32 n 32 VAL 32 B LEU 33 n 33 LEU 33 B GLU 34 n 34 GLU 34 B GLU 35 n 35 GLU 35 B MET 36 n 36 MET 36 B SER 37 n 37 SER 37 B LEU 38 n 38 LEU 38 B PRO 39 n 39 PRO 39 B GLY 40 n 40 GLY 40 B ARG 41 n 41 ARG 41 B TRP 42 n 42 TRP 42 B LYS 43 n 43 LYS 43 B PRO 44 n 44 PRO 44 B LYS 45 n 45 LYS 45 B MET 46 n 46 MET 46 B ILE 47 n 47 ILE 47 B HIS 48 n 48 HIS 48 B GLY 49 n 49 GLY 49 B ILE 50 n 50 ILE 50 B GLY 51 n 51 GLY 51 B GLY 52 n 52 GLY 52 B PHE 53 n 53 PHE 53 B ILE 54 n 54 ILE 54 B LYS 55 n 55 LYS 55 B VAL 56 n 56 VAL 56 B ARG 57 n 57 ARG 57 B GLN 58 n 58 GLN 58 B TYR 59 n 59 TYR 59 B ASP 60 n 60 ASP 60 B GLN 61 n 61 GLN 61 B ILE 62 n 62 ILE 62 B LEU 63 n 63 LEU 63 B ILE 64 n 64 ILE 64 B GLU 65 n 65 GLU 65 B ILE 66 n 66 ILE 66 B CYS 67 n 67 CYS 67 B GLY 68 n 68 GLY 68 B HIS 69 n 69 HIS 69 B LYS 70 n 70 LYS 70 B ALA 71 n 71 ALA 71 B ILE 72 n 72 ILE 72 B GLY 73 n 73 GLY 73 B THR 74 n 74 THR 74 B VAL 75 n 75 VAL 75 B LEU 76 n 76 LEU 76 B VAL 77 n 77 VAL 77 B GLY 78 n 78 GLY 78 B PRO 79 n 79 PRO 79 B THR 80 n 80 THR 80 B PRO 81 n 81 PRO 81 B VAL 82 n 82 VAL 82 B ASN 83 n 83 ASN 83 B ILE 84 n 84 ILE 84 B ILE 85 n 85 ILE 85 B GLY 86 n 86 GLY 86 B ARG 87 n 87 ARG 87 B ASN 88 n 88 ASN 88 B LEU 89 n 89 LEU 89 B LEU 90 n 90 LEU 90 B THR 91 n 91 THR 91 B GLN 92 n 92 GLN 92 B ILE 93 n 93 ILE 93 B GLY 94 n 94 GLY 94 B CYS 95 n 95 CYS 95 B THR 96 n 96 THR 96 B LEU 97 n 97 LEU 97 B ASN 98 n 98 ASN 98 B PHE 99 n 99 PHE 99 B author_and_software_defined_assembly PISA 2 dimeric 5230 -17 9130 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 A O HIS 69 A O HIS 69 A N ILE 66 A N ILE 66 A O GLU 65 A O GLU 65 A N LYS 14 A N LYS 14 A O VAL 11 A O VAL 11 A N ALA 22 A N ALA 22 A O LEU 23 A O LEU 23 A N ASN 83 A N ASN 83 A O LYS 43 A O LYS 43 A N GLN 58 A N GLN 58 A O ARG 57 A O ARG 57 A N VAL 77 A N VAL 77 B O GLN 18 B O GLN 18 B N ILE 15 B N ILE 15 B O LYS 14 B O LYS 14 B N GLU 65 B N GLU 65 B O ILE 62 B O ILE 62 B N GLY 73 B N GLY 73 B O LEU 33 B O LEU 33 B N LEU 76 B N LEU 76 B O VAL 75 B O VAL 75 B N TYR 59 B N TYR 59 B O ILE 54 B O ILE 54 B N ILE 47 B N ILE 47 1 -12.23 1.90 111.40 99.17 A A A CB CA C VAL VAL VAL 82 82 82 N 1 A PRO 39 -70.53 35.33 1 A CYS 67 37.44 56.74 1 B PRO 9 -69.91 76.03 1 B CYS 67 33.29 55.12 1 B PRO 79 -71.73 42.91 PARHCSDX.PRO TOPHCSDX.PRO INHPAR.PRO INHTOP.PRO 36.6 0.1850000 0.1850000 2.3 8. 8697 78. 1 MOLECULAR REPLACEMENT PDB ENTRY 1GNO 2.3 8. 59 1629 42 0 1528 0.013 1.8 28.5 1.7 37.0 2.3 100. 1A9M 8697 0.0730000 1 15. 3.0 78. 2.3 2.42 3. 0.3200000 2. 52.6 model building X-PLOR 3.1 refinement X-PLOR 3.1 data reduction SAINT data scaling SAINT phasing X-PLOR 3.1 G48H MUTANT OF HIV-1 PROTEASE IN COMPLEX WITH A PEPTIDIC INHIBITOR U-89360E 1 N N 1 N N 2 N N 3 N N 3 N N A ARG 87 A ARG 87 HELX_P A ILE 93 A ILE 93 1 1 7 B ARG 87 B ARG 87 HELX_P B LEU 90 B LEU 90 1 2 4 ASPARTYL PROTEASE ASPARTYL PROTEASE, DRUG RESISTANT, MUTATION given -0.417150 -0.748410 0.515620 -0.740240 -0.049360 -0.670530 0.527280 -0.661390 -0.533410 42.53785 96.42136 89.95747 POL_HV1PV UNP 1 1 P03368 FFREDLAFLQGKAREFSSEQTRANSPTISSEQTRANSPTRRELQVWGRDNNSPSEAGADRQGTVSFNFPQITLWQRPLVT IKIGGQLKEALLDTGADDTVLEEMSLPGRWKPKMIGGIGGFIKVRQYDQILIEICGHKAIGTVLVGPTPVNIIGRNLLTQ IGCTLNFPISPIETVPVKLKPGMDGPKVKQWPLTEEKIKALVEICTEMEKEGKISKIGPENPYNTPVFAIKKKDSTKWRK LVDFRELNKRTQDFWEVQLGIPHPAGLKKKKSVTVLDVGDAYFSVPLDEDFRKYTAFTIPSINNETPGIRYQYNVLPQGW KGSPAIFQSSMTKILEPFRKQNPDIVIYQYMDDLYVGSDLEIGQHRTKIEELRQHLLRWGLTTPDKKHQKEPPFLWMGYE LHPDKWTVQPIVLPEKDSWTVNDIQKLVGKLNWASQIYPGIKVRQLCKLLRGTKALTEVIPLTEEAELELAENREILKEP VHGVYYDPSKDLIAEIQKQGQGQWTYQIYQEPFKNLKTGKYARMRGAHTNDVKQLTEAVQKITTESIVIWGKTPKFKLPI QKETWETWWTEYWQATWIPEWEFVNTPPLVKLWYQLEKEPIVGAETFYVDGAANRETRLGKAGYLTNKGRQKVVPLTNTT NQKTELQAIYLALQDSGLEVNIVTDSQYALGIIQAQPDQSESELVNQIIEQLIKKQKVYLAWVPAHKGIGGNEQVDKLVS AGIRKILFLDGIDKAQDEHEKYHSNWRAMASDFNLPPVVAKEIVASCDKCQLKGEAMHGQVDCSPGIWQLDCTHLEGKVI LVAVHVASGYIEAEVIPAETGQETAYFLLKLAGRWPVKTIHTDNGSNFTSATVKAACWWAGIKQEFGIPYNPQSQGVVES MNKELKKIIGQVRDQAEHLKTAVQMAVFIHNFKRKGGIGGYSAGERIVDIIATDIQTKELQKQITKIQNFRVYYRDSRNP LWKGPAKLLWKGEGAVVIQDNSDIKVVPRRKAKIIRDYGKQMAGDDCVASRQDED 69 167 1A9M 1 99 P03368 A 1 1 99 69 167 1A9M 1 99 P03368 B 1 1 99 1 GLY engineered mutation HIS 48 1A9M A P03368 UNP 116 48 2 GLY engineered mutation HIS 48 1A9M B P03368 UNP 116 48 5 3 4 4 anti-parallel anti-parallel anti-parallel parallel anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel parallel anti-parallel anti-parallel A HIS 69 A HIS 69 A GLY 73 A GLY 73 A ILE 62 A ILE 62 A ILE 66 A ILE 66 A LEU 10 A LEU 10 A ILE 15 A ILE 15 A GLN 18 A GLN 18 A LEU 24 A LEU 24 A ASN 83 A ASN 83 A ILE 85 A ILE 85 A LYS 43 A LYS 43 A HIS 48 A HIS 48 A PHE 53 A PHE 53 A TYR 59 A TYR 59 A VAL 75 A VAL 75 A VAL 77 A VAL 77 B GLN 18 B GLN 18 B LEU 23 B LEU 23 B LEU 10 B LEU 10 B ILE 15 B ILE 15 B ILE 62 B ILE 62 B ILE 66 B ILE 66 B HIS 69 B HIS 69 B GLY 73 B GLY 73 B VAL 32 B VAL 32 B GLU 34 B GLU 34 B VAL 75 B VAL 75 B GLY 78 B GLY 78 B PHE 53 B PHE 53 B TYR 59 B TYR 59 B LYS 43 B LYS 43 B HIS 48 B HIS 48 BINDING SITE FOR RESIDUE U0E B 100 B U0E 100 Software 18 A ARG 8 A ARG 8 18 1_555 A ASP 25 A ASP 25 18 1_555 A GLY 27 A GLY 27 18 1_555 A GLY 49 A GLY 49 18 1_555 A VAL 82 A VAL 82 18 1_555 A ILE 84 A ILE 84 18 1_555 A HOH 102 D HOH 18 1_555 B LEU 23 B LEU 23 18 1_555 B ASP 25 B ASP 25 18 1_555 B GLY 27 B GLY 27 18 1_555 B ALA 28 B ALA 28 18 1_555 B ASP 29 B ASP 29 18 1_555 B ASP 30 B ASP 30 18 1_555 B ILE 47 B ILE 47 18 1_555 B HIS 48 B HIS 48 18 1_555 B GLY 49 B GLY 49 18 1_555 B ILE 50 B ILE 50 18 1_555 B VAL 82 B VAL 82 18 1_555 23 I 2 2 2